{
  "nctId": "NCT03894904",
  "briefTitle": "Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients",
  "officialTitle": "Double-Blind, Randomized, Controlled Trial, Small Volume Bolus of Papaverine Versus Heparin to Maintain Patency of Peripheral Arterial Catheters in Pediatric Patients Undergoing Surgical Procedures: Pilot Study",
  "protocolDocument": {
    "nctId": "NCT03894904",
    "filename": "Prot_001.pdf",
    "label": "Study Protocol",
    "date": "2019-08-05",
    "uploadDate": "2022-10-17T15:31",
    "size": 469846,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03894904/document/Prot_001.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 100,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2019-04-01",
    "completionDate": "2020-10-10",
    "primaryCompletionDate": "2020-10-10",
    "firstSubmitDate": "2019-03-27",
    "firstPostDate": "2019-03-29"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n\\- All patients age 0-17 years who would require elective placements of arterial catheters based on patients clinical complexity (ex. congenital heart disease) or based on the type of surgery (ex. open heart surgery).\n\nExclusion Criteria:\n\n* Patients with a history of significant liver dysfunction.\n* Patients undergoing liver transplants.\n* Patients with Grade 2 or more of intraventricular hemorrhage.\n* All preterm patients with a gestational age less than 37 weeks at the time of surgery.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "maximumAge": "17 Years",
    "stdAges": [
      "CHILD"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of Participants With Optimal Arterial Waveform",
        "description": "Optimal waveform was defined as easy aspiration of a blood sample (negative aspiration is easy and draws back freely without cavitation, and takes no more than 30 seconds to draw 1 mL), absence of color change at the catheter insertion site, and presence of a dicrotic notch in the arterial pressure waveform (a distinct dicrotic notch implies system has good resolution at higher frequencies and is not overdamped).",
        "timeFrame": "5 minutes after first dose"
      }
    ],
    "secondary": [
      {
        "measure": "Number of Participants With Optimal Arterial Waveform",
        "description": "Optimal waveform was defined as easy aspiration of a blood sample (negative aspiration is easy and draws back freely without cavitation, and takes no more than 30 seconds to draw 1 mL), absence of color change at the catheter insertion site, and presence of a dicrotic notch in the arterial pressure waveform (a distinct dicrotic notch implies system has good resolution at higher frequencies and is not overdamped).",
        "timeFrame": "60 minutes after first dose"
      },
      {
        "measure": "Number of Participants With Suboptimal Waveforms Who Received Rescue Papaverine and for Whom Papaverine Rescued Suboptimal Waveforms",
        "description": "These data were collected only from participants who received rescue papaverine. 7 in the Papaverine plus Heparin arm received rescue papaverine. 17 in the Heparin arm received rescue papaverine.",
        "timeFrame": "5 minutes after injection of rescue papaverine (about 70 minutes after first study drug dose and about 10 minutes after second study drug dose)"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 49,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:58.498Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}